Agenus director Wright acquires 1.18K stock units

Q: How many AGEN Deferred Stock Units did Timothy Wright acquire?

Timothy Wright acquired 1,178.7640 Deferred Stock Units on October 1, 2026, at $6.893 per unit under the Amended and Restated Directors' Deferred Compensation Plan.

Q: How was the AGEN Deferred Stock Unit price determined?

The $6.893 per-unit price was the average of the closing price of Agenus common stock for all trading days during the calendar quarter immediately preceding October 1, 2026.

Q: How do Timothy Wright's AGEN Deferred Stock Units convert and distribute?

The Deferred Stock Units convert into common stock on a one-for-one basis. Under the plan, the units are typically distributed once the director ceases to serve as a director.

The deferred units convert into common stock on a one-for-one basis under the directors’ plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Agenus Inc. director Timothy Wright acquired 1,178.7640 Deferred Stock Units on October 1, 2026, at $6.893 per unit under the company's Amended and Restated Directors' Deferred Compensation Plan. His reported direct holdings following the transaction were 29,807.7910 Deferred Stock Units. Under the plan, the units represent common stock to be distributed, typically once he ceases to serve as a director.

Insider Trade Summary

Grant/Award: 1,178.764 shares

Grant/Award 1 txn

Insider Wright Timothy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units ^{F1, F3, F2}	1,178.764	--	--

Holdings After Transaction: Deferred Stock Units — 29,807.791 contracts (Direct)

Footnotes (3)

F1. Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
F2. Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
F3. $6.893 per Deferred Stock Unit acquired on October 1, 2026. The price of each Deferred Stock Unit acquired on October 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

Key Figures

Deferred Stock Units acquired: 1,178.7640 Deferred Stock Units Price per Deferred Stock Unit: $6.893 per Deferred Stock Unit Direct Deferred Stock Units following transaction: 29,807.7910 Deferred Stock Units +1 more

4 metrics

Deferred Stock Units acquired 1,178.7640 Deferred Stock Units October 1, 2026

Price per Deferred Stock Unit $6.893 per Deferred Stock Unit Average closing price for all trading days in the preceding calendar quarter

Direct Deferred Stock Units following transaction 29,807.7910 Deferred Stock Units Reported position following the October 1, 2026 transaction

Conversion basis 1 Deferred Stock Unit for 1 share of common stock Conversion terms stated in the footnote

Key Terms

Deferred Stock Units, Directors' Deferred Compensation Plan, 1 for 1 basis

3 terms

Deferred Stock Units financial

"Deferred Stock Units convert to shares of Common Stock"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Directors' Deferred Compensation Plan financial

"Amended and Restated Directors' Deferred Compensation Plan"

1 for 1 basis technical

"convert to shares of Common Stock on a 1 for 1 basis"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AGEN Deferred Stock Units did Timothy Wright acquire?

Timothy Wright acquired 1,178.7640 Deferred Stock Units on October 1, 2026, at $6.893 per unit under the Amended and Restated Directors' Deferred Compensation Plan.

How was the AGEN Deferred Stock Unit price determined?

The $6.893 per-unit price was the average of the closing price of Agenus common stock for all trading days during the calendar quarter immediately preceding October 1, 2026.

How do Timothy Wright's AGEN Deferred Stock Units convert and distribute?

The Deferred Stock Units convert into common stock on a one-for-one basis. Under the plan, the units are typically distributed once the director ceases to serve as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/02/2026 - 03:25 PM Accepted by SEC EDGAR 10/02/2026 - 03:24 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright Timothy

(Last)

(First)

(Middle)

C/O AGENUS INC.

3 FORBES ROAD

(Street)

LEXINGTON

MASSACHUSETTS

02421

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGENUS INC [ AGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Units	⁽¹⁾	10/01/2026		A		1,178.764		⁽²⁾	⁽²⁾	Common Stock	1,178.764	⁽³⁾	29,807.791	D

Explanation of Responses:

1. Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

2. Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

3. $6.893 per Deferred Stock Unit acquired on October 1, 2026. The price of each Deferred Stock Unit acquired on October 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

	/s/Melissa Orilall as Attorney-in-Fact for Timothy R. Wright	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR